Thu, February 10, 2022
Wed, February 9, 2022
Tue, February 8, 2022

Matthew Harrison Maintained (AMGN) at Hold with Increased Target to $238 on, Feb 9th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-238-on-feb-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $235 to $238 on, Feb 9th, 2022.

Matthew has made no other calls on AMGN in the last 4 months.



There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $255 on, Wednesday, January 5th, 2022
  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $218 on, Tuesday, December 21st, 2021
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $194 on, Monday, November 22nd, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Hold and Held Target at $228 on, Friday, November 19th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $216 on, Wednesday, November 3rd, 2021


This is the rating of the analyst that currently disagrees with Matthew


  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $258 on, Monday, December 6th, 2021